`To:
`Cc:
`
`Subject:
`Date:
`
`White, Brandon (Perkins Coie)
`Trials
`TBlinka@cooley.com; JGraves@cooley.com; EScordino@cooley.com; Stephen.Hash@bakerbotts.com;
`Margaret.Sampson@bakerbotts.com; Jeff.Gritton@bakerbotts.com; apollack@buddlarner.com;
`dshelhoff@buddlarner.com; ssender@buddlarner.com; lweinstein@buddlarner.com; Greb, Emily J. (Perkins
`Coie); EsoNaproxen@perkinscoie.com; Bloodworth, Shannon (Perkins Coie)
`IPR2018-00272 & IPR2017-01995: Notice of Bankruptcy and Request for Teleconference
`Wednesday, August 29, 2018 11:19:08 AM
`
`Dear Board,
`
`On August 28, 2018, one of the Patent Owners, Pozen Inc., filed Suggestions of Bankruptcy in
`IPR2018-00272 and IPR2017-01995. Paper Nos. 12 and 50, respectively. Patent Owner
`asserts that these filings effect a stay of each of these IPRs by statute. Petitioners request a
`conference call as soon as possible to address the impact of these filings on the procedural
`schedule in these cases, if any, and any orders or briefing that may be necessary in view of
`these filings. Petitioners note that a deposition is scheduled for this coming Friday, August 31
`in IPR2017-01995, and Petitioners’ Reply brief deadline is Friday, September 7, 2018.
`
`Respectfully submitted,
`
`Brandon White
`Counsel for Petitioner Mylan Pharmaceuticals Inc.
`
`Brandon White | Perkins Coie LLP
`PARTNER
`700 Thirteenth Street, N.W. Suite 600
`Washington, DC 20005-3960
`D. +1.202.654.6206
`F. +1.202.654.9681
`E. BMWhite@perkinscoie.com
`
`
`NOTICE: This communication may contain privileged or other confidential information. If you have received it in error, please advise the
`sender by reply email and immediately delete the message and any attachments without copying or disclosing the contents. Thank you.
`
`